Temperature-Induced Changes in Reperfused Stroke: Inflammatory and Thrombolytic Biomarkers.

Although hyperthermia is associated with poor outcomes in ischaemic stroke (IS), some studies indicate that high body temperature may benefit reperfusion therapies. We assessed the association of temperature with effective reperfusion (defined as a reduction of ≥8 points in the National Institute of Health Stroke Scale (NIHSS) within the first 24 h) and poor outcome (modified Rankin Scale (mRS) > 2) in 875 retrospectively-included IS patients. We also studied the influence of temperature on thrombolytic (cellular fibronectin (cFn); matrix metalloproteinase 9 (MMP-9)) and inflammatory biomarkers (tumour necrosis factor-alpha (TNF-α), interleukin 6 (IL-6)) and their relationship with effective reperfusion. Our results showed that a higher temperature at 24 but not 6 h after stroke was associated with failed reperfusion (OR: 0.373, = 0.001), poor outcome (OR: 2.190, = 0.005) and higher IL-6 levels (OR: 0.958, < 0.0001). Temperature at 6 h was associated with higher MMP-9 levels (R = 0.697; < 0.0001) and effective reperfusion, although this last association disappeared after adjusting for confounding factors (OR: 1.178, = 0.166). Our results suggest that body temperature > 37.5 °C at 24 h, but not at 6 h after stroke, is correlated with reperfusion failure, poor clinical outcome, and infarct size. Mild hyperthermia (36.5-37.5 °C) in the first 6 h window might benefit drug reperfusion therapies by promoting clot lysis.